{"id":"doxofylline","rwe":[{"pmid":"41867466","year":"2026","title":"Effective Component Compatibility of Bufei Yishen Formula III Alleviates Pulmonary Vascular Inflammation in COPD: Via VEGF(165)/P38 MAPK Pathway.","finding":"","journal":"Journal of inflammation research","studyType":"Clinical Study"},{"pmid":"41456077","year":"2025","title":"Investigating the therapeutic mechanism of Bufei Decoction in COPD: Schisandrin B targets the TLR4/NF-κB/JAK-STAT signaling pathway.","finding":"","journal":"Hereditas","studyType":"Clinical Study"},{"pmid":"41298796","year":"2025","title":"Comparative effects of respiratory stimulants in mechanically ventilated patients: a network meta-analysis of randomized controlled trials.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"41089433","year":"2025","title":"Potential of doxofylline in the treatment of chronic obstructive airway diseases (Review).","finding":"","journal":"Biomedical reports","studyType":"Clinical Study"},{"pmid":"40735826","year":"2025","title":"A validated method for the determination of doxofylline and its pharmacokinetic application in healthy volunteers.","finding":"","journal":"Bioanalysis","studyType":"Clinical Study"}],"tags":[{"label":"doxofylline","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"R03DA11","category":"atc"},{"label":"Active","category":"status"},{"label":"Anti-Asthmatic Agents","category":"pharmacology"},{"label":"Antitussive Agents","category":"pharmacology"},{"label":"Bronchodilator Agents","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Phosphodiesterase Inhibitors","category":"pharmacology"},{"label":"Respiratory System Agents","category":"pharmacology"}],"phase":"phase_3","safety":{"safetySignals":[{"llr":96.096,"date":"","count":60,"signal":"Pneumonia","source":"DrugCentral FAERS","actionTaken":"Reported 60 times (LLR=96)"}],"commonSideEffects":[{"effect":"Pneumonia","drugRate":"LLR 96","severity":"common"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ansimar","offLabel":[],"synonyms":["doxofylline","ansimar","dioxyfilline","doxophylline"],"timeline":[],"approvals":[],"brandName":"Ansimar","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"doxofylline","explanation":"Imagine your airways are like a narrow road that gets congested. Doxofylline helps to relax the muscles around the road, making it wider and easier to breathe. This makes it easier for air to flow in and out of the lungs.","oneSentence":"Doxofylline works by stimulating the beta-2 adrenergic receptors in the lungs, causing bronchodilation.","technicalDetail":"Doxofylline acts as a selective beta-2 adrenergic receptor agonist, increasing the concentration of cyclic AMP in the airway smooth muscle cells, leading to bronchodilation and improved lung function."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/959","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=DOXOFYLLINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DOXOFYLLINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:50:37.181865","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:38:17.855038+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"diprophylline","drugSlug":"diprophylline","fdaApproval":"1951-03-07","relationship":"same-class"},{"drugName":"choline theophyllinate","drugSlug":"choline-theophyllinate","fdaApproval":"1981-11-05","relationship":"same-class"},{"drugName":"theophylline","drugSlug":"theophylline","fdaApproval":"1940-04-19","genericCount":53,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"doxofylline","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"diprophylline","brandName":"diprophylline","genericName":"diprophylline","approvalYear":"1951","relationship":"same-class"},{"drugId":"choline-theophyllinate","brandName":"choline theophyllinate","genericName":"choline theophyllinate","approvalYear":"1981","relationship":"same-class"},{"drugId":"theophylline","brandName":"theophylline","genericName":"theophylline","approvalYear":"1940","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06346691","phase":"PHASE4","title":"Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2024-03-01","conditions":["COPD"],"enrollment":20,"completionDate":"2024-11-15"},{"nctId":"NCT05154942","phase":"NA","title":"Vmax Detection of Acupuncture-doxofylline as a Whole Probe of CYP1A in Vivo","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2021-12-15","conditions":["Acupuncture","Drug Interaction"],"enrollment":10,"completionDate":"2023-11-15"},{"nctId":"NCT03388853","phase":"PHASE4","title":"Efficacy and Safety Study of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD.","status":"COMPLETED","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2018-02-20","conditions":["COPD"],"enrollment":68,"completionDate":"2019-12-21"},{"nctId":"NCT04238221","phase":"PHASE4","title":"Effect of add-on Doxofylline on Lung Function in Stable COPD","status":"UNKNOWN","sponsor":"University of Milan","startDate":"2020-09-01","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":78,"completionDate":"2020-11-30"},{"nctId":"NCT03879590","phase":"PHASE3","title":"Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma","status":"UNKNOWN","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2019-05","conditions":["Asthma Chronic","Asthma in Children"],"enrollment":60,"completionDate":"2019-12"},{"nctId":"NCT01055041","phase":"NA","title":"Controller Medications in the Management of Bronchial Asthma","status":"COMPLETED","sponsor":"Government Medical College, Bhavnagar","startDate":"2008-12","conditions":["Moderate to Severe Persistent Bronchial Asthma"],"enrollment":50,"completionDate":"2009-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"010905","UNII":"MPM23GMO7Z","CHEBI":"CHEBI:94714","INN_ID":"5156","UMLSCUI":"C0058721","ChEMBL_ID":"CHEMBL1527608","KEGG_DRUG":"D03898","DRUGBANK_ID":"DB09273","PDB_CHEM_ID":"7UH","PUBCHEM_CID":"50942","SNOMEDCT_US":"1173992002","MESH_SUPPLEMENTAL_RECORD_UI":"C029797"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.66 hours","clearance":"6.83 mL/min/kg","volumeOfDistribution":"1.03 L/kg"},"publicationCount":112,"therapeuticAreas":["Respiratory"],"atcClassification":{"source":"DrugCentral","atcCode":"R03DA11","allCodes":["R03DA11"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026","pmid":"41867466","title":"Effective Component Compatibility of Bufei Yishen Formula III Alleviates Pulmonary Vascular Inflammation in COPD: Via VEGF(165)/P38 MAPK Pathway.","journal":"Journal of inflammation research"},{"date":"2025 Dec 27","pmid":"41456077","title":"Investigating the therapeutic mechanism of Bufei Decoction in COPD: Schisandrin B targets the TLR4/NF-κB/JAK-STAT signaling pathway.","journal":"Hereditas"},{"date":"2025 Nov 26","pmid":"41298796","title":"Comparative effects of respiratory stimulants in mechanically ventilated patients: a network meta-analysis of randomized controlled trials.","journal":"Scientific reports"},{"date":"2025 Nov","pmid":"41089433","title":"Potential of doxofylline in the treatment of chronic obstructive airway diseases (Review).","journal":"Biomedical reports"},{"date":"2025 Jul","pmid":"40735826","title":"A validated method for the determination of doxofylline and its pharmacokinetic application in healthy volunteers.","journal":"Bioanalysis"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":0,"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:38:17.855038+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}